SERUM HS-CRP LEVELS DO NOT INDICATE THE SEVERITY OF LIVER DAMAGE IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS WITH TYPE-2 DIABETES MELLITUS
NOBEL MEDICUS, vol.6, no.2, pp.43-46, 2010 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 6 Issue: 2
- Publication Date: 2010
- Journal Name: NOBEL MEDICUS
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.43-46
- Keywords: Non-alcoholic steatohepatitis (NASH), type 2 diabetes mellitus, hs-CRP, liver enzymes, Brunt's classification system, C-REACTIVE PROTEIN, METABOLIC SYNDROME, DISEASE
- Eskisehir Osmangazi University Affiliated: No
Abstract
Objective: Non-alcoholic steatohepatitis (NASH) is a commonly encountered community health problem which is associated with obesity, insulin resistance and type 2 diabetes. There is no clinical or biochemical indicator predicting the prognosis of NASH. Therefore, it is not possible to predict the course of NASH in which patients may stay as a benign condition or in which it may progress to fibrosis or rarely cirrhosis. High sensitive C-reactive protein (hs-CRP) is a commonly used acute phase reactant which increases in even mild inflammatory states. In this study, we investigated the relationship between hs-CRP and inflammation in liver tissue in cases with NASH and type 2 diabetes mellitus.